FIELD: medicine, cardiovascular surgery in particular.
SUBSTANCE: invention relates to medicine, in particular cardiovascular surgery and angiology. The level of soluble endothelial protein C receptors (sEPCR) and the activity of clotting factor FVIII are determined in the peripheral venous blood of the patient. Then, the presence or absence of type 2 diabetes is assessed. Based on the obtained data, the indicator is calculated according to the original formula. After that, using the obtained z value, the probability of developing restenosis is calculated according to the original formula.
EFFECT: method makes it possible to predict the development of restenosis of the arterial reconstruction zone within a year after the intervention.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF RESTENOSIS IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES AFTER ENDOVASCULAR INTERVENTIONS | 2022 |
|
RU2788896C1 |
| METHOD FOR PREDICTING FATAL OUTCOMES IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF ARTERIES OF LOWER EXTREMITIES AFTER ENDOVASCULAR RECONSTRUCTIONS | 2021 |
|
RU2752823C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH INTERMITTENT CLAUDICATION DUE TO OBLITERATING ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES | 2021 |
|
RU2754502C1 |
| METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES WITH PRIOR CORONARY ARTERY STENTING | 2015 |
|
RU2582291C1 |
| METHOD OF FORECASTING PROGRESS OF RESTENOSIS AFTER CORONARY ARTERIES STENTING WITH STENTS WITHOUT DRUG COATING | 2009 |
|
RU2395091C1 |
| METHOD FOR INTEGRATED ENDOVASCULAR TREATMENT OF PATIENTS WITH DIABETES MELLITUS AND CARDIOVASCULAR COMORBIDITY | 2023 |
|
RU2827665C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE, HAVING UNDERGONE PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770273C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF THROMBOTIC COMPLICATIONS FOLLOWING RECONSTRUCTIVE-RESTORATIVE INTERVENTIONS ON MAIN ARTERIES OF LOWER EXTREMITIES | 2020 |
|
RU2740444C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RESTENOSIS OF THE RECONSTRUCTION ZONE AFTER ENDOVASCULAR INTERVENTIONS ON THE MAIN ARTERIES OF THE LOWER EXTREMITIES | 2021 |
|
RU2764155C1 |
